liu.seSearch for publications in DiVA
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma
Univ Zurich, Switzerland.
Univ Zurich, Switzerland.
Univ Zurich, Switzerland.
Univ Zurich, Switzerland.
Vise andre og tillknytning
2018 (engelsk)Inngår i: Oncogene, ISSN 0950-9232, E-ISSN 1476-5594, Vol. 37, nr 27, s. 3753-3762Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Human papillomavirus (HPV)-driven cutaneous squamous cell carcinoma (cSCC) is the most common cancer in immunosuppressed patients. Despite indications suggesting that HPV promotes genomic instability during cSCC development, the molecular pathways underpinning HPV-driven cSCC development remain unknown. We compared the transcriptome of HPV-driven mouse cSCC with normal skin and observed higher amounts of transcripts for Porcupine and WNT ligands in cSCC, suggesting a role for WNT signaling in cSCC progression. We confirmed increased Porcupine expression in human cSCC samples. Blocking the secretion of WNT ligands by the Porcupine inhibitor LGK974 significantly diminished initiation and progression of HPV-driven cSCC. Administration of LGK974 to mice with established cSCC resulted in differentiation of cancer cells and significant reduction of the cancer stem cell compartment. Thus, WNT/beta-catenin signaling is essential for HPV-driven cSCC initiation and progression as well as for maintaining the cancer stem cell niche. Interference with WNT secretion may thus represent a promising approach for therapeutic intervention.

sted, utgiver, år, opplag, sider
NATURE PUBLISHING GROUP , 2018. Vol. 37, nr 27, s. 3753-3762
HSV kategori
Identifikatorer
URN: urn:nbn:se:liu:diva-149856DOI: 10.1038/s41388-018-0244-xISI: 000437975200011PubMedID: 29662191OAI: oai:DiVA.org:liu-149856DiVA, id: diva2:1236442
Merknad

Funding Agencies|Swiss National Science Foundation (SNF); Swiss Cancer League; Promedica Foundation Zurich; University of Zurich Research Priority Program "Translational Cancer Research"; Kanton of Zurich

Tilgjengelig fra: 2018-08-02 Laget: 2018-08-02 Sist oppdatert: 2018-08-20

Open Access i DiVA

fulltext(4587 kB)96 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 4587 kBChecksum SHA-512
a5178d1f4bd2b3c3f7509acb034a753fd0650525b28a0aa44c0783006427b762c0e5798fb295c902f767848b177ad434c05d7c2d54e2fb8b578b031e3ab540c0
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Cantù, Claudio

Søk i DiVA

Av forfatter/redaktør
Cantù, Claudio
Av organisasjonen
I samme tidsskrift
Oncogene

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 96 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 120 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf